Literature DB >> 30293125

Visfatin and insulin levels and cigarette smoking are independent risk factors for hidradenitis suppurativa: a case-control study.

Neslihan Akdogan1, Nuran Alli2, Pinar Incel Uysal2, Canan Topcuoglu3, Tuba Candar4, Turan Turhan3.   

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. HS has been associated with obesity, adipokine imbalance, dyslipidemia, pro-inflammation, and metabolic syndrome (MS). The aim of this study was to determine the association between HS, and serum visfatin levels (SVLs), small-dense low-density lipoprotein cholesterol (sdLDL-C), and ischemia-modified albumin (IMA), as well as the association between HS, and smoking, alcohol consumption, anthropometric measurements, blood pressures (BPs), fasting blood glucose (FBG) and lipids, inflammatory markers, homocysteine, uric acid (UA), serum insulin levels (SILs), insulin resistance (IR) and MS, so as to identify relevant risk factors for HS. This case-control study included 40 patients (M/F: 23/17) and 40 age- and gender-matched controls (M/F: 23/17). Demographic data, smoking status and alcohol consumption, personal and family medical history, previous and current treatments were noted. Anthropometric data, BPs, FBG and lipids, homocysteine, UA, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and high-sensitivity CRP (hs-CRP), hemoglobin A1c (HbA1c), SILs, SVLs, IMA and sdLDL-C were measured. Homeostasis model assessment for IR (HOMA-IR) was calculated. The associations were made by univariate and multivariate analyses. Univariate analysis showed that there was a significant association between HS and smoking, pack-years of smoking, weight, body mass index (BMI), waist circumference (WC), triglycerides (TGs), high-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, SILs, CRP, hs-CRP, homocysteine, UA, ESR, HOMA-IR, SVLs, and MS. After adjusting for BMI and smoking status, the SVLs, SILs, and hs-CRP levels remained higher in the patients than in the controls (P = 0.02, P = 0.01, and P = 0.02, respectively). Multivariate analysis showed that there was a significant association between HS, and the SVLs and SILs, and smoking. Each unit increase in the SVL (P = 0.003, 95% CI 1.16-2.11) and SIL (P = 0.03, 95% CI 1.01-1.17) increased the risk of HS 1.56- and 1.09-fold, respectively. Furthermore, smoking was associated with a 14.87-fold increase in the risk of HS (P = 0.001, 95% CI 2.82-78.56). This study indicates that HS patients have higher SVLs, SILs, and hs-CRP levels than healthy controls-independent of BMI and smoking status. The SVL and SILs and smoking were independent risk factors for HS.

Entities:  

Keywords:  Hidradenitis suppurativa; Insulin; Smoking; Visfatin

Mesh:

Substances:

Year:  2018        PMID: 30293125     DOI: 10.1007/s00403-018-1867-z

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  11 in total

Review 1.  Surgical Management of Hidradenitis Suppurativa: A Narrative Review.

Authors:  Surbhi Chawla; Connor Toale; Marie Morris; A M Tobin; Dara Kavanagh
Journal:  J Clin Aesthet Dermatol       Date:  2022-01

2.  Evaluation of serum omentin-1 and apelin concentrations in patients with hidradenitis suppurativa.

Authors:  Marcos A González-López; J Gonzalo Ocejo-Viñals; Cristina Mata; Diego Díaz; Sandra Guiral; Virginia Portilla; Alfonso Corrales; M Carmen González-Vela; Miguel A González-Gay; Ricardo Blanco; José L Hernández
Journal:  Postepy Dermatol Alergol       Date:  2021-07-26       Impact factor: 1.837

3.  What's Race Got to Do With It? CRP Levels in Immune Mediated Skin Diseases: Considerations for Hidradenitis Suppurativa.

Authors:  Chidubem A V Okeke; Jonathan P Williams; Callyn U Iwuala; Pearl K Igwe; Raveena Khanna; Jessica D Perry; Ginette A Okoye; Angel S Byrd
Journal:  Front Immunol       Date:  2022-03-29       Impact factor: 7.561

4.  Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.

Authors:  Samuel Der Sarkissian; Schapoor Hessam; Joslyn S Kirby; Michelle A Lowes; Dillon Mintoff; Haley B Naik; Hans Christian Ring; Nisha Suyien Chandran; John W Frew
Journal:  JAMA Dermatol       Date:  2022-03-01       Impact factor: 11.816

Review 5.  Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms.

Authors:  John W Frew; Jason E Hawkes; James G Krueger
Journal:  Ther Adv Chronic Dis       Date:  2019-03-01       Impact factor: 5.091

6.  Association between vitiligo and smoking: A nationwide population-based study in Korea.

Authors:  Ji Hyun Lee; Yong Gyu Park; Young Bok Lee; Soo Young Lee; Dong Soo Yu; Kyung Do Han
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

Review 7.  Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.

Authors:  Amit Garg; Neeta Malviya; Andrew Strunk; Shari Wright; Afsaneh Alavi; Raed Alhusayen; Ali Alikhan; Steven D Daveluy; Isabelle Delorme; Noah Goldfarb; Wayne Gulliver; Iltefat Hamzavi; Tarannum Jaleel; Alexa B Kimball; Joslyn S Kirby; Mark G Kirchhof; Janice Lester; Hadar Lev-Tov; Michelle A Lowes; Robert Micheletti; Lauren A Orenstein; Vincent Piguet; Christopher Sayed; Jerry Tan; Haley B Naik
Journal:  J Am Acad Dermatol       Date:  2021-01-23       Impact factor: 15.487

Review 8.  Hidradenitis Suppurativa and 1-Carbon Metabolism: Role of Gut Microbiome, Matrix Metalloproteinases, and Hyperhomocysteinemia.

Authors:  Jack Molnar; Carissa Jo Mallonee; Dragana Stanisic; Rubens P Homme; Akash K George; Mahavir Singh; Suresh C Tyagi
Journal:  Front Immunol       Date:  2020-08-19       Impact factor: 7.561

9.  Serum irisin level, insulin resistance, and lipid profiles in patients with hidradenitis suppurativa: a case-control study.

Authors:  Ezgi Özkur; Yasemin Erdem; İlknur Kıvanç Altunay; Damla Demir; Nurcihan Çalışkan Dolu; Erdinç Serin; Aslı Aksu Çerman
Journal:  An Bras Dermatol       Date:  2020-09-11       Impact factor: 1.896

Review 10.  Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis.

Authors:  Viktor A Zouboulis; Konstantin C Zouboulis; Christos C Zouboulis
Journal:  Pharmaceutics       Date:  2021-12-26       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.